T-cell-targeted peptide epitope booster vaccine (yellow fever virus infection) (Emergex)

N/A

Report date: 2025/01/26 16:40:55

Base Information

Drug NameT-cell-targeted peptide epitope booster vaccine (yellow fever virus infection) (Emergex)
Drug Alias NameN/A
ClassificationVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineBiologics > Protein drugs > Recombinant polypeptideVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsYellow Fever
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGylden Pharma Ltd
China Registration ClassN/A

Develop Information

Active CompaniesGylden Pharma Ltd
Inactive CompaniesN/A
Active IndicationsYellow Fever
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A